Categories: News

Prognos Health And Datavant Expand Partnership

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

NEW YORK and SAN FRANCISCO, March 16, 2021 /PRNewswire/ — Prognos Health, a leading healthcare analytics platform company, and Datavant, the leader in helping healthcare organizations safely connect their data, today announced an expanded partnership that brings new value to life sciences brands. This partnership leverages Prognos’s expertise in accessing, managing and analyzing a vast ecosystem of data within Prognos MarketplaceTM and Datavant’s connectivity technology and network of data source partners to accelerate the time to value for acquiring purpose-built healthcare data assets.

“We are excited to deepen our partnership with Prognos as their Marketplace enables the rapid acquisition and integration of fit-for-purpose real-world datasets pulled from hundreds of disparate data sources. Today, data fragmentation is the greatest challenge in the use of healthcare data to improve patient outcomes,” said Travis May, co-founder and CEO, Datavant. “Our privacy-protecting connectivity technology combined with the power of the Prognos Marketplace will enable these life sciences brands to more efficiently find patient-centric, fit-for-purpose data sets.”

This collaboration will integrate Datavant’s extensive network of sources within the Prognos Marketplace, part of the company’s prognosFACTOR platform, to provide life science companies a single platform to acquire the healthcare data needed to address a variety of business needs. By leveraging Prognos Marketplace’s diverse and growing ecosystem of real-world data sources, users are able to define their ideal patient cohort and access key demographic, therapeutic and physician insights before purchasing the data for their specified cohort of patients. This ability to identify and select patient-level data brings greater value than the traditional method of purchasing data from multiple sources. The resulting HIPAA-compliant, multi-source patient cohort is delivered in a private cloud or to an application in a matter of minutes.

“Together with Datavant, we’re giving key healthcare stakeholders greater visibility into data options that offer deeper insights into specific patient cohorts, while providing speed, flexibility and control throughout the process,” commented Sundeep Bhan, CEO, Prognos Health. “This expanded partnership allows us to continue to push the boundaries of healthcare analytics to improve patient outcomes.”

“Integrating Datavant’s ever expanding ecosystem of partners greatly enhances the data available within the Prognos Marketplace,” said Theresa Greco, chief commercial officer, Prognos Health. “With dozens of sources and data for more than 325 million patients already available, Marketplace provides our customers with a more efficient way to acquire, manage and apply patient-centric healthcare data across a variety of business applications,”

This partnership comes at a critical time when the healthcare industry is striving to deliver more personalized therapies to improve health outcomes. Together, Prognos and Datavant are committed to transforming the way the healthcare industry accesses and benefits from healthcare data. By accelerating data-driven decisions with agile access to clinically-rich patient analytics, this partnership will lead to better and more cost effective outcomes for healthcare stakeholders.

About Prognos Health
Prognos Health is the leading clinically-focused data and analytics platform company. The prognosFACTOR platform has the power to query billions of fully-integrated lab and health records on more than 325 million de-identified patients to answer or uncover key healthcare questions in minutes, not months. Prognos enables the agile exchange of integrated, patient-centric data between key healthcare stakeholders directly from the Prognos Marketplace. Leveraging the company’s patent-pending technology, clients and partners benefit from a range of analytics applications, including cohort design, patient journey studies, omnichannel marketing and more. For more information, visit prognoshealth.com.

About Datavant
Datavant’s mission is to connect the world’s health data to improve patient outcomes. Datavant works to reduce the friction of data sharing across the healthcare industry by building technology that protects the privacy of patients while supporting the linkage of de-identified patient records across datasets. Datavant is headquartered in San Francisco. Learn more about Datavant at www.datavant.com.

Media Contacts:
Prognos Health | Brianna Taylor | btaylor@garfieldgroup.com
Datavant | Sarah Rowe, Head of Marketing | pr@datavant.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/prognos-health-and-datavant-expand-partnership-301248392.html

SOURCE Prognos Health

Staff

Recent Posts

Think Together Expands Executive Team with Matt Scharpnick as Chief of Innovation

Think Together creates new C-suite role to fuel market innovation and transform educational outcomes as…

2 hours ago

MindHYVE.ai™ and Islamabad Diagnostic Centre Forge Strategic Alliance to Launch AGI-Powered Diagnostic Intelligence Across Pakistan

ISLAMABAD, May 22, 2025 /PRNewswire/ -- In a groundbreaking move to elevate clinical diagnostics nationwide,…

2 hours ago

Hexaware Accelerates Delivery Solutions with a New Office in Chicago

CHICAGO, May 22, 2025 /PRNewswire/ -- Hexaware Technologies (NSE: HEXT), a leading global IT services…

8 hours ago

Bulletin from the Annual General Meeting 2025

The Annual General Meeting 2025 of RaySearch Laboratories AB (publ) was held on May 22, 2025,…

8 hours ago

Lofta and Bloom Mental Health Partner to Bridge the Gap Between Sleep Apnea and Mental Health

SAN DIEGO, May 22, 2025 /PRNewswire/ -- Lofta, a leader in at-home sleep apnea testing…

8 hours ago

AMA Establishes CPT Codes for Minimally Invasive ESD Procedure

CENTER VALLEY, Pa., May 22, 2025 /PRNewswire/ -- Olympus Corporation, a global medical technology company…

8 hours ago